<DOC>
	<DOC>NCT00806026</DOC>
	<brief_summary>This purpose of this study is to investigate the efficacy and tolerability of pregabalin in treating idiopathic RLS patients for up to 12 months.</brief_summary>
	<brief_title>Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>idiopathic RLS with the presence of all four clinical manifestations of RLS RLS symptoms occur predominantly in the evening RLS history at least 6 months IRLS =&gt; 15 at the beginning and the end of placebo runin Have =&gt;15 nights with RLS symptoms in the month prior to screening Any secondary RLS Current augmentation due to RLS treatment Placebo responders identified during the placebo runin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>RLS</keyword>
</DOC>